…
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Pro-Dex, Inc. manufactures precision components and subassemblies for medical, dental and industrial equipment. Long-term growth drivers include outsourcing of medical and dental device manufacturing, aging-population healthcare demand, and wider adoption of minimally invasive technologies that may benefit precision suppliers. Investors may find the company attractive for its specialized manufacturing capabilities and exposure to healthcare end markets.
Material risks include customer concentration and cyclical capital spending in medical devices, competition from larger contract manufacturers, and execution or supply-chain issues that could pressure margins.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | 9.43M | 4.71M | 5.63M | 7.90M | 5.45M |
| Net income | 7.07M | 3.85M | 4.45M | 6.11M | 4.15M |
| Selling general administrative | 4.03M | 4.90M | 4.08M | 3.19M | 2.49M |
| Selling and marketing expenses | 0.15M | 0.09M | 0.59M | 0.58M | 0.41M |
| Gross profit | 12.75M | 13.13M | 13.57M | 13.14M | 9.78M |
| Reconciled depreciation | 0.86M | 0.73M | 0.69M | 0.57M | 0.44M |
| Ebit | 6.06M | 5.12M | 4.53M | 7.07M | 5.00M |
| Ebitda | 6.91M | 5.96M | 5.34M | 8.68M | 5.74M |
| Depreciation and amortization | 0.86M | 0.84M | 0.81M | 1.61M | 0.74M |
| Non operating income net other | - | - | 1.45M | 1.07M | 0.67M |
| Operating income | 5.76M | 5.12M | 4.53M | 7.07M | 5.00M |
| Other operating expenses | 40.33M | 36.88M | 33.50M | 27.77M | 22.18M |
| Interest expense | 0.53M | 0.46M | 0.35M | 0.24M | 0.22M |
| Tax provision | 2.35M | 0.85M | 1.18M | 1.79M | 1.30M |
| Interest income | 0.29M | 0.08M | 0.13M | 0.10M | 0.27M |
| Net interest income | -0.24M | -0.39M | -0.23M | -0.14M | 0.05M |
| Extraordinary items | - | - | - | - | 0.01M |
| Non recurring | - | - | - | -0.01M | -0.01M |
| Income tax expense | 2.35M | 0.85M | 1.18M | 1.79M | 1.30M |
| Total revenue | 46.09M | 42.04M | 38.03M | 34.83M | 27.17M |
| Total operating expenses | 6.99M | 7.97M | 9.05M | 6.08M | 4.79M |
| Cost of revenue | 33.34M | 28.91M | 24.45M | 21.69M | 17.39M |
| Total other income expense net | 3.90M | -0.42M | 1.10M | 0.84M | 0.45M |
| Net income from continuing ops | 7.07M | 3.85M | 4.45M | 6.11M | 4.15M |
| Net income applicable to common shares | 7.07M | 3.85M | 4.45M | 6.11M | 4.15M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 51.82M | 47.33M | 40.32M | 31.13M | 25.52M |
| Intangible assets | 0.08M | 0.12M | 0.19M | 0.16M | 0.13M |
| Other current assets | 1.92M | 1.50M | 0.63M | 0.30M | 1.05M |
| Total liab | 20.23M | 23.66M | 20.24M | 12.06M | 8.51M |
| Total stockholder equity | 31.59M | 23.67M | 20.08M | 19.06M | 17.01M |
| Deferred long term liab | - | - | - | - | 0.15M |
| Other current liab | 2.72M | 2.75M | 2.20M | 2.41M | 1.44M |
| Common stock | 6.77M | 7.68M | 7.95M | 12.75M | 15.81M |
| Capital stock | 6.77M | 7.68M | 7.95M | 12.75M | 15.81M |
| Retained earnings | 24.82M | 15.99M | 12.35M | 7.90M | 1.74M |
| Other liab | 0.01M | 0.54M | 0.40M | 0.80M | 0.31M |
| Other assets | 0.04M | 0.84M | 0.53M | 0.30M | 0.30M |
| Cash | 2.94M | 0.85M | 3.72M | 6.42M | 7.74M |
| Total current liabilities | 9.68M | 10.81M | 5.87M | 5.23M | 4.27M |
| Current deferred revenue | 0.45M | 1.01M | 0.15M | 0.20M | 0.21M |
| Net debt | 11.86M | 14.74M | 11.48M | 0.26M | -3.19M |
| Short term debt | 4.24M | 3.29M | 1.24M | 0.65M | 0.62M |
| Short long term debt | 3.83M | 3.29M | 1.24M | 0.65M | 0.62M |
| Short long term debt total | 14.79M | 15.59M | 15.20M | 6.68M | 4.56M |
| Other stockholder equity | - | - | -0.21M | 0.41M | 0.45M |
| Property plant equipment | 13.20M | 13.42M | 3.85M | 5.63M | 2.73M |
| Total current assets | 30.98M | 31.17M | 25.01M | 22.67M | 21.78M |
| Long term investments | 7.52M | 1.78M | 1.70M | 2.36M | 0.58M |
| Net tangible assets | 31.51M | 23.55M | 19.90M | 18.90M | 16.88M |
| Short term investments | 1.13M | 0.76M | 1.29M | 2.56M | 2.65M |
| Net receivables | 9.95M | 15.38M | 10.93M | 5.16M | 4.10M |
| Long term debt | 8.91M | 10.25M | 11.54M | 3.28M | 3.93M |
| Inventory | 16.17M | 12.68M | 8.44M | 8.24M | 6.24M |
| Accounts payable | 2.26M | 3.76M | 2.29M | 1.97M | 2.00M |
| Accumulated other comprehensive income | - | - | -0.21M | -1.59M | -0.55M |
| Common stock total equity | - | - | 7.95M | 12.75M | 15.81M |
| Retained earnings total equity | - | - | 12.35M | 7.90M | 1.74M |
| Non currrent assets other | 0.03M | 0.04M | 0.07M | 0.04M | 0.04M |
| Deferred long term asset charges | - | - | - | - | 0.26M |
| Non current assets total | 20.84M | 16.16M | 15.31M | 8.45M | 3.74M |
| Capital lease obligations | 2.05M | 2.05M | 2.43M | 3.09M | - |
| Long term debt total | - | - | 11.54M | 3.28M | 3.93M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -0.89M | 0.44M | 4.60M | -1.73M | 0.17M |
| Change to liabilities | -2.17M | 2.85M | -0.46M | 0.63M | 0.22M |
| Total cashflows from investing activities | -0.89M | -1.24M | -3.71M | -2.29M | -1.22M |
| Net borrowings | -0.81M | 0.76M | 8.79M | -0.63M | 4.51M |
| Total cash from financing activities | -2.49M | -0.79M | 3.09M | -3.98M | 0.45M |
| Change to operating activities | 0.71M | -0.85M | -0.35M | 0.75M | -0.72M |
| Net income | 7.07M | 3.85M | 4.45M | 6.11M | 4.15M |
| Change in cash | 2.09M | -2.87M | -2.70M | -1.32M | 2.55M |
| Begin period cash flow | 0.85M | 3.72M | 6.42M | 7.74M | 5.19M |
| End period cash flow | 2.94M | 0.85M | 3.72M | 6.42M | 7.74M |
| Total cash from operating activities | 5.46M | -0.85M | -2.08M | 5.90M | 3.33M |
| Issuance of capital stock | - | - | - | - | 0.00M |
| Depreciation | 0.86M | 0.73M | 0.69M | 0.57M | 0.44M |
| Other cashflows from investing activities | - | - | -0.04M | -0.04M | -0.00M |
| Dividends paid | 0.09M | - | 0.26M | 0.01M | 0.02M |
| Change to inventory | -3.49M | -4.24M | -0.20M | -2.00M | -1.85M |
| Change to account receivables | 5.43M | -4.45M | -5.78M | -1.06M | -1.13M |
| Sale purchase of stock | -1.55M | -1.61M | -5.54M | -3.39M | -3.98M |
| Other cashflows from financing activities | -0.22M | 2.00M | 9.49M | 0.04M | 4.99M |
| Change to netincome | -2.88M | 1.10M | -0.60M | 0.24M | 1.08M |
| Capital expenditures | 0.97M | 1.67M | 8.31M | 0.56M | 1.40M |
| Change receivables | - | - | -5.78M | -1.06M | -1.13M |
| Cash flows other operating | - | - | -0.22M | 0.44M | 0.41M |
| Cash and cash equivalents changes | - | - | -2.70M | -1.32M | 2.55M |
| Change in working capital | 0.40M | -6.54M | -6.69M | -1.08M | -2.35M |
| Stock based compensation | 0.77M | 1.27M | 0.90M | 0.29M | 0.04M |
| Other non cash items | -3.90M | 0.17M | -1.25M | 0.03M | -0.37M |
| Free cash flow | 4.49M | -2.52M | -10.38M | 5.33M | 1.93M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PDEX Pro-Dex Inc |
2.59 4.49% |
60.24 | 35.13 | 13.07 | 1.31 | 1.99 | 1.45 | 12.50 |
| ISRG Intuitive Surgical Inc |
3.88 0.89% |
440.75 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
-2.00 0.95% |
208.00 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-1.89 1.80% |
103.04 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
-0.66 0.33% |
197.94 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard Lee Van Kirk Jr. | CEO & Director | 1961 |
| Ms. Alisha K. Charlton | CFO & Corp. Sec. | 1970 |
| Mr. Richard Lee Van Kirk Jr. | CEO, President, COO & Director | 1961 |
| Ms. Alisha K. Charlton | CFO & Corporate Secretary | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.